D2G Oncology is a precision-oncology company based in Mountain View, California, reported to have been founded in 2018 by Ian Winters. Public company descriptions characterize its work as applying quantitative and multiplexed functional cancer genomics to relate drugs to genotypes in order to advance precision cancer therapeutics. The company operates INSITE, a login-gated internal research portal at www.d2g-insite.com supporting preclinical study management and result exploration. D2G Oncology publishes no public developer API program, no developer portal, no API documentation, and no client SDKs, and third-party company trackers list the company as inactive as of 2026. It was surfaced through the Lightspeed Venture Partners portfolio and is retained here as an identity-only profile.
D2G Oncology is profiled on the APIs.io network. Tagged areas include Company, Oncology, Healthcare, Biotechnology, and Therapeutics.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/d2g-oncology: open an issue to ask a question, or submit a pull request to add artifacts.
Submit an artifact on GitHub — free →Manage your own listing — the Influence plan, $499/mo →
aid: d2g-oncology
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source: []
generated: '2026-07-22'
method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/d2g-oncology.png
name: D2G Oncology
description: D2G Oncology is a precision-oncology company based in Mountain View, California, reported to have been founded
in 2018 by Ian Winters. Public company descriptions characterize its work as applying quantitative and multiplexed functional
cancer genomics to relate drugs to genotypes in order to advance precision cancer therapeutics. The company operates INSITE,
a login-gated internal research portal at www.d2g-insite.com supporting preclinical study management and result exploration.
D2G Oncology publishes no public developer API program, no developer portal, no API documentation, and no client SDKs, and
third-party company trackers list the company as inactive as of 2026. It was surfaced through the Lightspeed Venture Partners
portfolio and is retained here as an identity-only profile.
url: https://raw.githubusercontent.com/api-evangelist/d2g-oncology/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- lightspeed-venture-partners
x-tier: stub
x-tier-reason: no-public-api-program
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Oncology
- Healthcare
- Biotechnology
- Therapeutics
- Life Sciences
- Precision Medicine
- Functional Genomics
apis: []
common:
- type: DomainSecurity
url: security/d2g-oncology-domain-security.yml
- type: Website
url: https://www.d2g-insite.com/
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
x-enrichment:
date: '2026-07-20'
status: minimal
artifacts_added: 1
pass: local-v1
x-notes:
no-api-program: 'Enrichment pass 2026-07-20 found no public developer API surface: no developer portal, no documentation
site, no consumer-facing OpenAPI/AsyncAPI/GraphQL, no first-party SDKs in npm, PyPI, Maven Central, NuGet, RubyGems, Packagist
or crates.io, and no usable /.well-known artifacts. Every path probed on www.d2g-insite.com returns the single-page-app
shell with HTTP 200 (soft 404), so security.txt, llms.txt, openid-configuration and api-catalog are all absent despite
returning 200 status codes.'
domain-warning: d2goncology.com is NO LONGER controlled by D2G Oncology. As of 2026-07-20 that domain serves an unrelated
Dubai travel business (Andaleeb Travel Agency) and presents a TLS certificate valid only for *.web-hosting.com. Do not
add it as a company property in future enrichment rounds. The only live company-controlled property found is www.d2g-insite.com.
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →